Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?

被引:33
作者
Katic, Bozena J. [1 ,2 ]
Krause, Steven J. [3 ]
Tepper, Stewart J. [3 ]
Hu, Henry X. [1 ]
Bigal, Marcelo E. [4 ,5 ]
机构
[1] Merck & Co Inc, Global Outcomes Res, Whitehouse Stn, NJ USA
[2] Temple Univ, Sch Pharm, Ctr Pharmaceut Hlth Serv Res, Philadelphia, PA 19122 USA
[3] Cleveland Clin, Neurol Inst, Ctr Headache & Pain, Cleveland, OH 44106 USA
[4] Merck & Co Inc, Sci Affairs, Whitehouse Stn, NJ USA
[5] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源
HEADACHE | 2010年 / 50卷 / 01期
关键词
medication adherence; triptan; underutilization; medication compliance; acute migraine treatment; migraine treatment decision; BEHAVIORAL FACILITATION; PROPHYLACTIC MEDICATION; CONSULTING BEHAVIOR; PATIENT-ADHERENCE; FUTURE-DIRECTIONS; CLINICAL-PRACTICE; HEADACHE PATIENTS; DECISION-MAKING; ANALGESIC USE; TRIPTANS;
D O I
10.1111/j.1526-4610.2009.01535.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Proper use of medications is an important part of successfully managing migraine headache, yet migraineurs frequently switch, discontinue, or delay taking effective prescription therapies such as triptans. Medication persistence in the treatment of chronic-episodic disorders such as migraine is not well understood. In this article we review this topic, by critically reviewing studies conducted using pharmacy claims, clinical records, survey, and patient-reported data to explore acute medication use for migraine headache. While efficacy, cost, drug tolerability, and side effects impact whether a patient takes migraine medication, low perceived disease importance and factors related to the patient's internal decision-making process play a strong role in the sustained use of acute medication for migraine attack. We propose a model that combines the patient's perceived severity of migraine, their beliefs regarding the safety of acute medications, and factors related to the physician-patient relationship to identify migraineurs at high risk for medication adherence problems.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 66 条
[21]   Analgesic drug taking: Beliefs and behavior among headache patients [J].
Ferrari, A ;
Stefani, M ;
Sternieri, S ;
Bertolotti, M ;
Sternieri, E .
HEADACHE, 1997, 37 (02) :88-94
[22]   Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine [J].
Foley, KA ;
Cady, R ;
Martin, V ;
Adelman, J ;
Diamond, M ;
Bell, CF ;
Dayno, JM ;
Hu, XH .
HEADACHE, 2005, 45 (05) :538-545
[23]   What do patients want from acute migraine treatment? [J].
Gallagher, RM .
CEPHALALGIA, 2004, 24 :8-15
[24]   Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment [J].
Gallagher, RM ;
Kunkel, R .
HEADACHE, 2003, 43 (01) :36-43
[25]  
Gillissen A, 2007, J PHYSIOL PHARMACOL, V58, P205
[26]   Chronic disorders with episodic manifestations: focus on epilepsy and migraine [J].
Haut, SR ;
Bigal, ME ;
Lipton, RB .
LANCET NEUROLOGY, 2006, 5 (02) :148-157
[27]   Beliefs about medicines and adherence among Swedish migraineurs [J].
Hedenrud, Tove ;
Jonsson, Pernilla ;
Linde, Mattias .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (01) :39-45
[28]   Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness [J].
Horne, R ;
Weinman, J .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1999, 47 (06) :555-567
[29]   Triptans - Why once? [J].
Ifergane, Gal ;
Wirguin, Itzhak ;
Shvartzman, Pesach .
HEADACHE, 2006, 46 (08) :1261-1263
[30]   Decision making in migraine patients taking sumatriptan: An exploratory study [J].
Ivers, H ;
McGrath, PJ ;
Purdy, A ;
Hennigar, AW ;
Campbell, MA .
HEADACHE, 2000, 40 (02) :129-136